MiR-7-5p was described as being able to inhibit melanoma growth and metastasis through the inactivation of NF-κB signaling, which leads to the decreased of NF-κB target genes expression, such as IL-1β, IL-6 and IL-8 [89]. Here, NFKB1 is linked to melanoma.